Expert Guidance to Optimize Therapy Decisions for Head and Neck Squamous Cell Carcinoma

This comprehensive program gathers expert insights into the management of patients with locoregionally advanced and metastatic HNSCC, featuring an Interactive Decision Support Tool that lets clinicians compare their treatment choices for specific patient scenarios with those of 5 experts. Also included is a complementary expert-authored CME/CE/CPE-certified module with downloadable slideset with a focus on the most clinically important developments in leveraging checkpoint inhibitors for HNSCC.
Barbara Burtness, MD

Downloadable Slideset

Emerging clinical data and expert guidance on checkpoint inhibitors and other treatment options for head and neck squamous cell carcinoma.

Barbara Burtness, MD Released: September 3, 2019
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley

Supported by educational grants from
Bristol-Myers Squibb
Merck & Co., Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?